Correlation Between Antibe Therapeutics and GB Sciences
Can any of the company-specific risk be diversified away by investing in both Antibe Therapeutics and GB Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibe Therapeutics and GB Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antibe Therapeutics and GB Sciences, you can compare the effects of market volatilities on Antibe Therapeutics and GB Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibe Therapeutics with a short position of GB Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibe Therapeutics and GB Sciences.
Diversification Opportunities for Antibe Therapeutics and GB Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Antibe and GBLX is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antibe Therapeutics and GB Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GB Sciences and Antibe Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibe Therapeutics are associated (or correlated) with GB Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GB Sciences has no effect on the direction of Antibe Therapeutics i.e., Antibe Therapeutics and GB Sciences go up and down completely randomly.
Pair Corralation between Antibe Therapeutics and GB Sciences
If you would invest 0.03 in GB Sciences on September 16, 2024 and sell it today you would earn a total of 0.51 from holding GB Sciences or generate 1700.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Antibe Therapeutics vs. GB Sciences
Performance |
Timeline |
Antibe Therapeutics |
GB Sciences |
Antibe Therapeutics and GB Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Antibe Therapeutics and GB Sciences
The main advantage of trading using opposite Antibe Therapeutics and GB Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibe Therapeutics position performs unexpectedly, GB Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GB Sciences will offset losses from the drop in GB Sciences' long position.Antibe Therapeutics vs. Grey Cloak Tech | Antibe Therapeutics vs. CuraScientific Corp | Antibe Therapeutics vs. Love Hemp Group | Antibe Therapeutics vs. Greater Cannabis |
GB Sciences vs. Antibe Therapeutics | GB Sciences vs. Awakn Life Sciences | GB Sciences vs. America Great Health | GB Sciences vs. Therasense |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |